Effect of modification of the physicochemical properties of ICAM-1-derived peptides on internalization and intracellular distribution in the human Leukemic cell Line HL-60

Molecular Pharmaceutics

Volumn 6, Issue 2, 2009, Pages 396-406

  Majumdar, Sumit ^a,b   Tejo, Bimo A ^a,c   Badawi, Ahmed H ^a   Moore, David ^a   Krise, Jeffrey P ^a   Siahaan, Teruna J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b BD Technologies   (United States)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Doxorubicin; Drug conjugate; Endocytosis; Hl 60 cells; Icam 1 peptide; LFA 1

Indexed keywords

DOXORUBICIN CYCLO(1,8)CYSTEINYLPROLYLARGINYLGLYCYLGLYCYLSERYLVALYLCYSTEINE CONJUGATE; DOXORUBICIN DERIVATIVE; DOXORUBICIN PEGYLATED CYCLO(1,8)CYSTEINYLPROLYLARGINYLGLYCYLGLYCYLSERYLVALYLCYSTEINE CONJUGATE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DIFFUSION; DRUG UPTAKE; HUMAN; HUMAN CELL; HYDROPHILICITY; INTERNALIZATION; PEPTIDE SYNTHESIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; ENDOCYTOSIS; HL-60 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PEPTIDES, CYCLIC; SUBCELLULAR FRACTIONS;

EID: 64649102159     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp800120t     Document Type: Article

References (31)

1. Nagy, A.; Armatis, P.; Cai, R. Z.; Szepeshazi, K.; Halmos, G.; Schally, A. V. Design, Synthesis, and in Vitro Evaluation of Cytotoxic Analogs of Bombesin-Like Peptides Containing Doxo- rubicin or Its Intensely Potent Derivative, 2-Pyrrolinodoxorubicin. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 652-656.
2. Nagy, A.; Schally, A. V.; Armatis, P.; Szepeshazi, K.; Halmos, G.; Kovacs, M.; Zarandi, M.; Groot, K.; Miyazaki, M.; Jungwirth, A.; Horvath, J. Cytotoxic Analogs of Luteinizing Hormone- Releasing Hormone Containing Doxorubicin or 2-Pyrrolinodoxo- rubicin, a Derivative 500-1000 Times More potent. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 7269-7273.
3. Nagy, A.; Schally, A. V.; Halmos, G.; Armatis, P.; Cai, R. Z.; Csernus, V.; Kovacs, M.; Koppan, M.; Szepeshazi, K.; Kahan, Z. Synthesis and Biological Evaluation of Cytotoxic Analogs of Somatostatin Containing Doxorubicin or Its Intensely Potent Derivative, 2-Pyrrolinodoxorubicin. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 1794-1799.
4. Anderson, M. E.; Siahaan, T. J. Targeting ICAM-1/LFA-1 Interaction for Controlling Autoimmune Diseases: Designing Peptide and Small Molecule Inhibitors. Peptides 2003, 24, 487-501.
5. Dunehoo, A. L.; Anderson, M. E.; Majumdar, S.; Kobayashi, N.; Berkland, C.; Siahaan, T. J. Cell Adhesion Molecules for Targeted Drug Delivery. J. Pharm. Sci. 2006, 95, 1856-1872.
6. Nagy, A.; Schally, A. V. Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone-Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A "Smarter" Chemotherapy. Curr. Pharm. Des. 2005, 11, 1167-1180.
7. Lu, Y.; Yang, J.; Sega, E. Issues Related to Targeted Delivery of Proteins and Peptides. AAPS J. 2006, 8, E466-478.
8. Lai, B. T.; Gao, J. P.; Lanks, K. W. Mechanism of Action and Spectrum of Cell Lines Sensitive to a Doxorubicin-Transferrin Conjugate. Cancer Chemother. Pharmacol. 1998, 41, 155-160.
9. Garnett, M. C. Targeted Drug Conjugates: Principles and Progress. Adv. Drug Delivery Rev. 2001, 53, 171-216.
10. van Hensbergen, Y.; Broxterman, H. J.; Elderkamp, Y. W.; Lankelma, J.; Beers, J. C.; Heijn, M.; Boven, E.; Hoekman, K.; Pinedo, H. M. A Doxorubicin-Cngrc-Peptide Conjugate with Prodrug Properties. Biochem. Pharmacol. 2002, 63, 897-908.
11. Kratz, F.;Beyer, U.; Roth, T.; Tarasova, N.; Collery, P.; Lechenault, F.; Cazabat, A.; Schumacher, P.; Unger, C.; Falken, U. Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy. J. Pharm. Sci. 1998, 87, 338-346.
12. Froesch, B. A.; Stahel, R. A.; Zangemeister-Wittke, U. Preparation and Functional Evaluation of New Doxorubicin Immunoconju- gates Containing an Acid-Sensitive Linker on Small-Cell Lung Cancer Cells. Cancer Immunol. Immunother. 1996, 42, 55-63.
13. Chaires, J. B.; Satyanarayana, S.; Suh, D.; Fokt, I.; Przewloka, T.; Priebe, W. Parsing the Free Energy of Anthracycline Antibiotic Binding to DNA. Biochemistry 1996, 35, 2047-2053.
14. Majumdar, S.; Kobayashi, N.; Krise, J. P.; Siahaan, T. J. Mechanism of Internalization of an ICAM-1-Derived Peptide by Human Leukemic Cell Line Hl-60: Influence of Physicochemical Properties on Targeted Drug Delivery. Mol. Pharmaceutics 2007, 4, 749-758.
15. Kruger, M.; Beyer, U.; Schumacher, P.; Unger, C.; Zahn, H.; Kratz, F. Synthesis and Stability of Four Maleimide Derivatives of the Anticancer Drug Doxorubicin for the Preparation of Chemoimmunoconjugates. Chem. Pharm. Bull. 1997, 45, 399-401.
16. Garsky, V. M.; Lumma, P. K.; Feng, D. M.; Wai, J.; Ramjit, H. G.; Sardana, M. K.; Oliff, A.; Jones, R. E.; DeFeo-Jones, D.; Freidinger, R. M. The Synthesis of a Prodrug of Doxorubicin Designed to Provide Reduced Systemic Toxicity and Greater Target Efficacy. J. Med. Chem. 2001, 44, 4216-4224.
17. Denmeade, S. R.; Nagy, A.; Gao, J.; Lilja, H.; Schally, A. V.; Isaacs, J. T. Enzymatic Activation of a Doxorubicin-Peptide Prodrug by Prostate-Specific Antigen. Cancer Res. 1998, 58, 2537-2540.
18. Iskandarsyah; Tejo, B. A.; Tambunan, U. S.; Verkhivker, G.; Siahaan, T. J. Structural Modifications of ICAM-1 Cyclic Peptides to Improve the Activity to Inhibit Heterotypic Adhesion of T Cells. Chem. Biol. Drug Des. 2008, 72, 27-33.
19. Gursoy, R. N.; Siahaan, T. J. Binding and Internalization of an ICAM-1 Peptide by the Surafce Receptors of T Cells. J. Pept. Res. 1999, 53, 414-421.
20. Dalmark, M.; Storm, H. H. A Fickian Diffusion Transport Process with Features of Transport Catalysis. Doxorubicin Transport in Human Red Blood Cells. J. Gen. Physiol. 1981, 78, 349-364.
21. Baravalle, G.; Schober, D.; Huber, M.; Bayer, N.; Murphy, R. F.; Fuchs, R. Transferrin Recycling and Dextran Transport to Lysosomes Is Differentially Affected by Bafilomycin, Nocodazole, and Low Temperature. Cell Tissue Res. 2005, 320, 99-113.
22. Anderson, M. E.; Siahaan, T. J. Mechanism of Binding and Internalization of ICAM-1-Derived Cyclic Peptides by LFA-1 on the Surface of T Cells: A Potential Method for Targeted Drug Delivery. Pharm. Res. 2003, 20, 1523-1532.
23. Anderson, M. E.; Tejo, B. A.; Yakovleva, T.; Siahaan, T. J. Characterization of Binding Properties of ICAM-1 Peptides to LFA-1: Inhibitors of T-Cell Adhesion. Chem. Biol. Drug Des. 2006, 68, 20-28.
24. Zimmerman, T.; Oyarzabal, J.; Sebastian, E. S.; Majumdar, S.; Tejo, B. A.; Siahaan, T. J.; Blanco, F. J. ICAM-1 Peptide Inhibitors of T-Cell Adhesion Bind to the Allosteric Site of LFA- 1. An NMR Characterization. Chem. Biol. Drug Des. 2007, 70, 347-353.
25. Anderson, M. E.; Yakovleva, T.; Hu, Y.; Siahaan, T. J. Inhibition of ICAM-1/LFA-1-Mediated Heterotypic T-Cell Adhesion to Epithelial Cells: Design of ICAM-1 Cyclic Peptides. Bioorg. Med. Chem. Lett. 2004, 14, 1399-1402.
26. Gursoy, R. N.; Jois, D. S.; Siahaan, T. J. Structural Recognition of an ICAM-1 Peptide by Its Receptor on the Surface of T Cells: Conformational Studies of Cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly- Ser-Val-Leu-Val-Thr-Gly-Cys-Oh. J. Pept. Res. 1999, 53, 422-431.
27. Eksborg, S. Extraction of Daunorubicin and Doxorubicin and Their Hydroxyl Metabolites: Self-Association in Aqueous Solution. J. Pharm. Sci. 1978, 67, 782-785.
28. Barthelemy-Clavey, V.; Maurizot, J.-C.; Dimicoli, J.-L.; Sicard, P. Self-Association of Daunorubicin. FEBS Lett. 1974, 46, 5-10.
29. Skovsgaard, T. Carrier-Mediated Transport of Daunorubicin, Adriamycin, and Rubidazone in Ehrlich Ascites Tumour Cells. Biochem. Pharmacol. 1978, 27, 1221-1227.
30. Fabbri, M.; Di Meglio, S.; Gagliani, M. C.; Consonni, E.; Molteni, R.; Bender, J. R.; Tacchetti, C.; Pardi, R. Dynamic Partitioning into Lipid Rafts Controls the Endo-Exocytic Cycle of the Alphal/ Beta2 Integrin, LFA-1, During Leukocyte Chemotaxis. Mol. Biol. Cell 2005, 16, 5793-5803.
31. Razani, B.; Lisanti, M. P. Caveolins and Caveolae: Molecular and Functional Relationships. Exp. Cell Res. 2001, 271, 36-44.